Response to "Doubt about the feasibility of preemptive genotyping"
Clin Pharmacol Ther
.
2013 Mar;93(3):234.
doi: 10.1038/clpt.2012.223.
Epub 2012 Nov 7.
Authors
J C Denny
,
J S Schildcrout
,
J M Pulley
,
D M Roden
PMID:
23249779
DOI:
10.1038/clpt.2012.223
No abstract available
Publication types
Letter
Comment
MeSH terms
Drug-Related Side Effects and Adverse Reactions* / genetics*
Female
Humans
Male
Patient Safety*
Pharmacogenetics / methods*
Grants and funding
U19 HL065962/HL/NHLBI NIH HHS/United States